Abstract
While viewed as the "guardian of the genome", the importance of the tumor suppressor p53 protein has increasingly gained ever more recognition in modulating additional modes of action related to cell death. Slowly but surely, its importance has evolved from a mutated genetic locus heavily implicated in a wide array of cancer types to modulating lysosomal-mediated cell death either directly or indirectly through the transcriptional regulation of the key signal transduction pathway intermediates involved in this. As an important step in determining the fate of cells in response to cytotoxicity or during stress response, lysosomal-mediated cell death has also become strongly interwoven with the key components that give the lysosome functionality in the form of the cathepsin proteases. While a number of articles have been published highlighting the independent input of p53 or cathepsins to cellular homeostasis and disease progression, one key area that warrants further focus is the regulatory relationship that p53 and its isoforms share with such proteases in regulating lysosomal-mediated cell death. Herein, we review recent developments that have shaped this relationship and highlight key areas that need further exploration to aid novel therapeutic design and intervention strategies.
Original language | English |
---|---|
Article number | 3476 |
Pages (from-to) | 1-20 |
Number of pages | 20 |
Journal | Cancers |
Volume | 12 |
Issue number | 11 |
DOIs | |
Publication status | Published - 22 Nov 2020 |
Keywords
- Apoptosis
- Cancer
- Cathepsin
- Lysosomal membrane permeabilization
- MOMP
- P53
Research Beacons, Institutes and Platforms
- Manchester Cancer Research Centre